chr4-112963140-G-C

Variant names:

• chr4-112963140-G-C
• rs17045162
• ENST00000506722.5:c.21+58626G>C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_Strong BA1

The ENST00000506722.5(ANK2):​c.21+58626G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.086 in 152,096 control chromosomes in the GnomAD database, including 902 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

• Frequency: Genomes: 𝑓 0.086 (902 hom., cov: 32)
• Consequence: ANK2 ENST00000506722.5 intron
• Clinical Significance: Not reported in ClinVar
• Conservation: PhyloP100: -0.0360
• Publications: 1 publications found

Genes affected

ANK2 (HGNC:493): (ankyrin 2) This gene encodes a member of the ankyrin family of proteins that link the integral membrane proteins to the underlying spectrin-actin cytoskeleton. Ankyrins play key roles in activities such as cell motility, activation, proliferation, contact and the maintenance of specialized membrane domains. Most ankyrins are typically composed of three structural domains: an amino-terminal domain containing multiple ankyrin repeats; a central region with a highly conserved spectrin binding domain; and a carboxy-terminal regulatory domain which is the least conserved and subject to variation. The protein encoded by this gene is required for targeting and stability of Na/Ca exchanger 1 in cardiomyocytes. Mutations in this gene cause long QT syndrome 4 and cardiac arrhythmia syndrome. Multiple transcript variants encoding different isoforms have been described. [provided by RefSeq, Dec 2011]

ANK2 Gene-Disease associations (from GenCC):

• complex neurodevelopmental disorder

  Inheritance: AD Classification: DEFINITIVE, MODERATE Submitted by: Ambry Genetics, ClinGen
• Brugada syndrome

  Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Genomics England PanelApp, ClinGen
• catecholaminergic polymorphic ventricular tachycardia

  Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: ClinGen, Genomics England PanelApp
• heart conduction disease

  Inheritance: AD Classification: LIMITED Submitted by: Genomics England PanelApp
• neurodevelopmental disorder

  Inheritance: AD Classification: LIMITED Submitted by: G2P
• cardiac arrhythmia, ankyrin-B-related

  Inheritance: Unknown, AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
• long QT syndrome

  Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

ACMG classification

Our verdict: Benign. The variant received -12 ACMG points.

• BP4: Computational evidence support a benign effect (BayesDel_noAF=-0.88).
• BA1: GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.191 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000506722.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected	Gene	Transcript	Tags	HGVSc	HGVSp	Effect	Exon Rank	Protein	UniProt
	ANK2	NM_001386142.1		c.21+58626G>C		intron	N/A	NP_001373071.1
	ANK2	NM_001386143.1		c.21+58626G>C		intron	N/A	NP_001373072.1
	ANK2	NM_001386186.2		c.73-211276G>C		intron	N/A	NP_001373115.1

Ensembl Transcripts

Selected	Gene	Transcript	Tags	HGVSc	HGVSp	Effect	Exon Rank	Protein	UniProt
	ANK2	ENST00000506722.5	TSL:1	c.21+58626G>C		intron	N/A	ENSP00000421067.1
	ANK2	ENST00000672209.1		c.21+58626G>C		intron	N/A	ENSP00000499982.1
	ANK2	ENST00000673298.1		c.21+58626G>C		intron	N/A	ENSP00000500245.1

Frequencies

GnomAD3 genomes AF: 0.0859 AC: 13054 AN: 151978 Hom.: 896 Cov.: 32

Gnomad AFR AF: 0.194

Gnomad AMI AF: 0.0779

Gnomad AMR AF: 0.0742

Gnomad ASJ AF: 0.0505

Gnomad EAS AF: 0.0306

Gnomad SAS AF: 0.0126

Gnomad FIN AF: 0.0257

Gnomad MID AF: 0.0665

Gnomad NFE AF: 0.0434

Gnomad OTH AF: 0.0862

We have no GnomAD4 exomes data on this position. Probably position not covered by the project.

GnomAD4 genome AF: 0.0860 AC: 13086 AN: 152096 Hom.: 902 Cov.: 32 AF XY: 0.0841 AC XY: 6255 AN XY: 74344

African (AFR) AF: 0.195 AC: 8070 AN: 41490

American (AMR) AF: 0.0741 AC: 1132 AN: 15282

Ashkenazi Jewish (ASJ) AF: 0.0505 AC: 175 AN: 3464

East Asian (EAS) AF: 0.0307 AC: 159 AN: 5182

South Asian (SAS) AF: 0.0122 AC: 59 AN: 4820

European-Finnish (FIN) AF: 0.0257 AC: 272 AN: 10600

Middle Eastern (MID) AF: 0.0646 AC: 19 AN: 294

European-Non Finnish (NFE) AF: 0.0434 AC: 2948 AN: 67942

Other (OTH) AF: 0.0858 AC: 181 AN: 2110

Alfa AF: 0.0737 Hom.: 86

Bravo AF: 0.0966

Asia WGS AF: 0.0320 AC: 112 AN: 3474

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name	Calibrated prediction	Score	Prediction
BayesDel_noAF	Benign	-0.88
CADD	Benign	1.6
DANN	Benign	0.41
PhyloP100		-0.036
Mutation Taster		=100/0	polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Other links and lift over

dbSNP: rs17045162; hg19: chr4-113884296;